| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V32547 | (R)-CE3F4 | 1593478-56-8 | (R)-CE3F4 is a potent and specific inhibitor of cAMP-activated exchange protein 1 (Epac1) with IC50 of 4.2 μM and is 10 times more selective for Epac2 (IC50, 44 μM). |
|
V39615 | (R)-DNMDP | 1630760-60-9 | (R)-DNMDP is a potent and specific cancer/tumor cell killer. |
|
V31555 | (R)-Equol | 221054-79-1 | (R)-Equol is an agonist for ERα and ERβ with Kis of 27.4 and 15.4 nM, respectively. |
|
V41989 | (R)-GSK-3685032 | 2170140-50-6 | (R)-GSK-3685032 is the R-isomer of GSK-3685032. |
|
V38952 | (R)-Hydroxychloroquine | 137433-23-9 | (R)-Hydroxychloroquine [(R)-HCQ]is the R-enantiomer of Hydroxychloroquine which is anantimalarial drug that inhibits Toll-like receptor 7/9 (TLR7/9) signaling, and shows efficiently against SARS-CoV-2. |
|
V39641 | (R)-JNJ-31020028 | 1094873-17-2 | (R)-JNJ-31020028 is a high-affinity, selective, BBB (blood-brain barrier) permeable/penetrable neuropeptide Y Y2 receptor blocker (antagonist) with pIC50 for human, rat and mouse Y2 receptors. |
|
V40339 | (R)-Lercanidipine D3 HCl | 1217724-52-1 | (R)-Lercanidipine-d3 (HCl) is the deuterium labelled form of (R)-Lercanidipine (HCl). |
|
V40323 | (R)-Lercanidipine HCl | 187731-34-6 | (R)-Lercanidipine HCl is the R-enantiomer of Lercanidipine. |
|
V38884 | (R)-Leucic acid | 20312-37-2 | (S)-Leucic acid is an amino acid (AA) metabolite. |
|
V40102 | (R)-Linezolid | 872992-20-6 | (R)-Linezolid is an impurity of Linezolid (PNU-100766). |
|
V32224 | (R)-MIK665 | 1799831-02-9 | (R)-MIK665 (MIK-665) is the less active R-enantiomer of MIK665, which is a novel and potent anticancer agent and Mcl-1 inhibitor with an IC50 of 1.81 nM. |
|
V40129 | (R)-Mirtazapine | 61364-37-2 | (R)-Mirtazapine is the R-enantiomer of Mirtazapine(Avanza; Zispin; Remeron), which is a 5-HT2/3 receptor inhibitor approved in 1990 as an atypical antidepressant forthe treatment of depression. |
|
V40291 | (R)-Mirtazapine D3 | 61364-37-2 | (R)-Mirtazapine D3 is a tri-deuterated form of (R)-Mirtazapine, the R-enantiomer of Mirtazapine. |
|
V40413 | (R)-Nicardipine | 76093-35-1 | (R)-Nicardipine ((R)-YC-93 free base) is the less active R-enantiomer of Nicardipine. |
|
V40678 | (R)-NVS-ZP7-4 | (R)-NVS-ZP7-4 is the R-isomer of NVS-ZP7-4. | |
|
V37679 | (R)-Plevitrexed | 153537-74-7 | (R)-Plevitrexed ((R)-ZD 9331; (R)-BGC9331) is the less active R-isomer of Plevitrexed. |
|
V40391 | (R)-Praziquantel D11 | 1399880-38-6 | (R)-Praziquantel-d11 is the deuterium labelled form of (R)-Praziquantel. |
|
V37764 | (R)-PS210 | 1410101-89-1 | (R)-PS210 is the R enantiomer of PS210 (compound 4h-eutomer) and is a substrate-selective allosteric activator of PDK1 with an AC50 value of 1.8 μM. |
|
V32010 | (R)-Rivastigmine D6 tartrate | 194930-00-2 | (S)-Rivastigmine-d6 (tartrate) is a deuterium labelled form of(S)-Rivastigmine. |
|
V42007 | (R)-RP-6306 | 2719793-91-4 | (R)-RP-6306 may be utilized to study Myt1-mediated diseases and cancer types to slow cancer progression. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
